Funded Tech Companies

MethylGene

MethylGene is a leading biopharmaceutical company, based in San Diego. Financial backing was provided by .

Company Overview

Contact Information

Company Background Information

Overview

MethylGene (TSX: MYG) is a publicly-traded biopharmaceutical company listed on the Toronto Stock Exchange under the symbol MYG. We focus in the areas of cancer, infectious disease and other diseases such as diabetes, Huntington's and inflammation.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

Financing History

No transactions have been recorded for this company.

Management Team

Title

Name

Email & Social

Chief Executive Officer

Charles Baum

        

Chief Medical Officer

Isan Chen

        

Chief Operating Officer

Mark Gergen

        

Chief Scientific Officer

James Christensen

        

VP - Finance

Jamie Donadio

        

VP - Product Management

Dennis Hester

        

Company Investors

No investors have been recorded for this company.

Browse more funded tech companies:

Methylation Sciences | Metica

Share this article

About Our VC Deals Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary